4-(5-bromo-2-methylphenyl)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine

ID: ALA4576021

PubChem CID: 83666328

Max Phase: Preclinical

Molecular Formula: C13H14BrN3

Molecular Weight: 292.18

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(Br)cc1C1NCCc2nc[nH]c21

Standard InChI:  InChI=1S/C13H14BrN3/c1-8-2-3-9(14)6-10(8)12-13-11(4-5-15-12)16-7-17-13/h2-3,6-7,12,15H,4-5H2,1H3,(H,16,17)

Standard InChI Key:  HGCUYOQOTUBYPS-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 17 19  0  0  0  0  0  0  0  0999 V2000
   20.2812  -15.8238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2812  -16.6410    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.9865  -17.0455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9865  -15.4111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6918  -15.8238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6962  -16.6374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4714  -16.8847    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9462  -16.2238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4642  -15.5682    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.9869  -17.8626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2771  -18.2698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2772  -19.0862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9857  -19.4953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6955  -19.0819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6919  -18.2668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5695  -19.4949    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   22.3981  -17.8556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  3 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 12 16  1  0
 15 17  1  0
M  END

Associated Targets(Human)

CA6 Tclin Carbonic anhydrase VI (993 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA4 Tclin Carbonic anhydrase IV (2163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA1 Tclin Carbonic anhydrase I (13240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 292.18Molecular Weight (Monoisotopic): 291.0371AlogP: 2.72#Rotatable Bonds: 1
Polar Surface Area: 40.71Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.56CX Basic pKa: 7.77CX LogP: 2.47CX LogD: 1.94
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.85Np Likeness Score: -0.65

References

1. Akocak S, Lolak N, Bua S, Nocentini A, Karakoc G, Supuran CT..  (2019)  α-Carbonic anhydrases are strongly activated by spinaceamine derivatives.,  27  (5): [PMID:30683554] [10.1016/j.bmc.2019.01.017]

Source